These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15793800)

  • 1. Physicochemical characterization of ricobendazole: I. Solubility, lipophilicity, and ionization characteristics.
    Wu Z; Razzak M; Tucker IG; Medlicott NJ
    J Pharm Sci; 2005 May; 94(5):983-93. PubMed ID: 15793800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sodium salt of the enantiomers of ricobendazole: Preparation, solubility and chiroptical properties.
    Cirilli R; Guglielmi P; Formica FR; Casulli A; Carradori S
    J Pharm Biomed Anal; 2017 May; 139():1-7. PubMed ID: 28258982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the complexation of albendazole with cyclodextrins for the design of new antiparasitic formulations.
    Pradines B; Gallard JF; Iorga BI; Gueutin C; Loiseau PM; Ponchel G; Bouchemal K
    Carbohydr Res; 2014 Oct; 398():50-5. PubMed ID: 25240182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue compatibility and pharmacokinetics of three potential subcutaneous injectables for low-pH drug solutions.
    Wu Z; Tucker IG; Razzak M; McSporran K; Medlicott NJ
    J Pharm Pharmacol; 2010 Jul; 62(7):873-82. PubMed ID: 20636875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Fluorescence Emission for Characterization of Albendazole and Ricobendazole Micellar Systems: Elucidation of the Molecular Mechanism of Drug Solubilization Process.
    Priotti J; Leonardi D; Pico G; Lamas MC
    AAPS PharmSciTech; 2018 Apr; 19(3):1152-1159. PubMed ID: 29218582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic study of cyclodextrins complexation with benzimidazolic antihelmintics in different reaction media.
    Bernad-Bernad MJ; Gracia-Mora J; Díaz D; Castillo-Blum SE
    Curr Drug Discov Technol; 2008 Jun; 5(2):146-53. PubMed ID: 18673253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
    Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
    J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the interaction between S(--) bupivacaine and 2-hydroxypropyl-beta-cyclodextrin.
    Moraes CM; Abrami P; de Paula E; Braga AF; Fraceto LF
    Int J Pharm; 2007 Feb; 331(1):99-106. PubMed ID: 17071028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of albendazole beta-cyclodextrin complexes.
    Castillo JA; Palomo-Canales J; Garcia JJ; Lastres JL; Bolas F; Torrado JJ
    Drug Dev Ind Pharm; 1999 Dec; 25(12):1241-8. PubMed ID: 10612019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexation and solubility behavior of albendazole with some cyclodextrins.
    Díaz D; Bernad Bernad MJ; Gracia Mora J; Escobar Llanos CM
    Pharm Dev Technol; 1998 Aug; 3(3):395-403. PubMed ID: 9742560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.
    See E; Zhang W; Liu J; Svirskis D; Baguley BC; Shaw JP; Wang G; Wu Z
    Int J Pharm; 2014 Oct; 473(1-2):528-35. PubMed ID: 25079434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexation of albendazole with hydroxypropyl-β-cyclodextrin significantly improves its pharmacokinetic profile, cell cytotoxicity and antitumor efficacy in nude mice.
    Ehteda A; Galettis P; Chu SW; Pillai K; Morris DL
    Anticancer Res; 2012 Sep; 32(9):3659-66. PubMed ID: 22993303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of curcumin-cyclodextrin inclusion complexation in aqueous solutions containing various alcoholic co-solvents and alginates using an UV-VIS titration method. Studies of curcumin and curcuminoides, XXXV.
    Hegge AB; Másson M; Kristensen S; Tønnesen HH
    Pharmazie; 2009 Jun; 64(6):382-9. PubMed ID: 19618675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical properties of valsartan and the effect of ethyl alcohol, propylene glycol and pH on its solubility.
    Mbah CJ
    Pharmazie; 2005 Nov; 60(11):849-50. PubMed ID: 16320948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties of carbovir, a potential anti-HIV agent.
    Anderson BD; Chiang CY
    J Pharm Sci; 1990 Sep; 79(9):787-90. PubMed ID: 2273460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.